NASDAQ:NAMS | Profit Breakdown | NewAmsterdam Pharma Co N.V.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$3.7M-$64.86M-$64.14M-$64.14M
2026-03-31$3.04M-$58.42M-$48.44M-$48.44M
2025-12-31$32,000.00-$65.98M-$74.92M-$74.92M
2025-09-30$348,000.00-$55.14M-$72.01M-$72.01M
2025-06-30$19.15M-$35.64M-$17.36M-$17.36M
2025-03-31$2.98M-$68.93M-$39.53M-$39.53M
2024-12-31$12.77M-$43.23M-$92.18M-$92.18M
2024-09-30$29.11M-$25M-$16.65M-$16.65M
2024-06-30$2.28M-$52.58M-$39.01M-$39.01M
2024-03-31$1.4M-$55.48M-$93.77M-$93.77M
2023-12-31$803,000.00-$51.07M-$49.47M-$49.5M
2023-09-30$2.94M-$49.56M-$47.13M-$47.13M
2023-06-30$1.72M-$42.48M-$38.29M-$38.29M
2023-03-31$8.63M-$39.85M-$42.02M-$42.02M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$22.5M-$225.68M-$203.82M-$203.82M
2024-12-31$45.56M-$176.29M-$241.6M-$241.6M
2023-12-31$14.09M-$182.97M-$176.91M-$176.94M
2022-12-31$102.69M-$3.56M-$22.63M-$22.63M
2021-12-31-$34.98M-$41.79M-$41.79M